Clinical Trial Update: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight [Phase 3]

View source ↗

Summary

Phase 3 trial update for tirzepatide in adults with type 2 diabetes and overweight/obesity, completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2024-04-08